DK0633879T3 - Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme - Google Patents

Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme

Info

Publication number
DK0633879T3
DK0633879T3 DK93907975T DK93907975T DK0633879T3 DK 0633879 T3 DK0633879 T3 DK 0633879T3 DK 93907975 T DK93907975 T DK 93907975T DK 93907975 T DK93907975 T DK 93907975T DK 0633879 T3 DK0633879 T3 DK 0633879T3
Authority
DK
Denmark
Prior art keywords
phenyl
treatment
enantiomeric
ethylamine
pyridinyl
Prior art date
Application number
DK93907975T
Other languages
Danish (da)
English (en)
Inventor
Ronald Conrad Griffith
Robert John Murray
Michael Balestra
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207339A external-priority patent/GB9207339D0/en
Priority claimed from GB929208290A external-priority patent/GB9208290D0/en
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0633879T3 publication Critical patent/DK0633879T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/10Antiepileptics; Anticonvulsants for petit-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/12Antiepileptics; Anticonvulsants for grand-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK93907975T 1992-04-03 1993-04-01 Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme DK0633879T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
GB929208290A GB9208290D0 (en) 1992-04-15 1992-04-15 Pharmaceutical compound having neuroprotective properties
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
DK0633879T3 true DK0633879T3 (da) 1998-09-28

Family

ID=26300643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907975T DK0633879T3 (da) 1992-04-03 1993-04-01 Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme

Country Status (29)

Country Link
EP (1) EP0633879B1 (ru)
JP (2) JP3120810B2 (ru)
KR (1) KR100259567B1 (ru)
CN (1) CN1044367C (ru)
AT (1) ATE163925T1 (ru)
AU (2) AU3897693A (ru)
CA (1) CA2133427C (ru)
CZ (1) CZ288519B6 (ru)
DE (1) DE69317411T2 (ru)
DK (1) DK0633879T3 (ru)
DZ (1) DZ1677A1 (ru)
ES (1) ES2115055T3 (ru)
FI (1) FI105025B (ru)
HK (1) HK1009331A1 (ru)
HU (1) HU211529A9 (ru)
IL (1) IL105276A (ru)
MA (1) MA22866A1 (ru)
MX (1) MX9301935A (ru)
MY (1) MY110149A (ru)
NO (1) NO302170B1 (ru)
NZ (1) NZ251384A (ru)
PL (1) PL180014B1 (ru)
RU (1) RU2128650C1 (ru)
SG (1) SG47948A1 (ru)
SK (1) SK281258B6 (ru)
TW (1) TW282455B (ru)
UA (1) UA29437C2 (ru)
WO (1) WO1993020052A1 (ru)
ZA (1) ZA932415B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
EP0648489A1 (en) * 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
WO2007017652A2 (en) * 2005-08-10 2007-02-15 Astrazeneca Ab Arylakylamines for the treatment of cancer
SG171928A1 (en) 2008-12-24 2011-07-28 Astrazeneca Ab Ethanamine compounds and their use for treating depression
JP2015501652A (ja) 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag Gabr−a2診断
PT3066091T (pt) 2013-11-05 2019-07-11 Astrazeneca Ab Pro-farmacos de antagonista de nmda
US20230190719A1 (en) * 2020-06-23 2023-06-22 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648489A1 (en) * 1988-08-12 1995-04-19 Fisons Corporation Arylalkylamides having neuroprotective properties

Also Published As

Publication number Publication date
EP0633879B1 (en) 1998-03-11
TW282455B (ru) 1996-08-01
AU3897693A (en) 1993-11-08
SG47948A1 (en) 1998-04-17
EP0633879A1 (en) 1995-01-18
CN1081669A (zh) 1994-02-09
NO302170B1 (no) 1998-02-02
NZ251384A (en) 1996-10-28
SK117794A3 (en) 1995-05-10
MA22866A1 (fr) 1993-12-31
CZ240994A3 (en) 1995-12-13
CA2133427C (en) 2003-06-10
MX9301935A (es) 1994-08-31
ZA932415B (en) 1993-10-22
SK281258B6 (sk) 2001-01-18
DE69317411T2 (de) 1998-07-30
CN1044367C (zh) 1999-07-28
NO943645L (no) 1994-11-16
IL105276A0 (en) 1993-08-18
IL105276A (en) 1997-06-10
HU211529A9 (en) 1995-11-28
NO943645D0 (no) 1994-09-30
PL180014B1 (pl) 2000-11-30
CA2133427A1 (en) 1993-10-14
FI944546A (fi) 1994-09-30
FI944546A0 (fi) 1994-09-30
AU7545696A (en) 1997-02-13
RU2128650C1 (ru) 1999-04-10
JP2000319259A (ja) 2000-11-21
CZ288519B6 (cs) 2001-07-11
DE69317411D1 (de) 1998-04-16
AU705419B2 (en) 1999-05-20
JPH07505385A (ja) 1995-06-15
WO1993020052A1 (en) 1993-10-14
HK1009331A1 (en) 1999-05-28
UA29437C2 (ru) 2000-11-15
DZ1677A1 (fr) 2002-02-17
MY110149A (en) 1998-02-28
KR100259567B1 (ko) 2000-07-01
JP3120810B2 (ja) 2000-12-25
FI105025B (fi) 2000-05-31
ES2115055T3 (es) 1998-06-16
ATE163925T1 (de) 1998-03-15
RU94042465A (ru) 1996-07-20

Similar Documents

Publication Publication Date Title
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
ATE131048T1 (de) Arzneimittel.
DK0959888T3 (da) Anvendelse af det chelerende middel clioquinol til fremstillingen af et farmaceutisk præparat til behandlingen af Alzheimer's sygdom
ATE187063T1 (de) Arzneimittel
DK0633879T3 (da) Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme
DE59201902D1 (de) Verstellbarer Rollstuhl.
NO911429D0 (no) Stoffbehandling.
AU4333893A (en) Use of guanosine and its precursors and derivatives in the manufacture of drugs for the treatment of brain dysfunction
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
NO911430D0 (no) Stoffbehandlingsmetode.
DE69102024D1 (de) Kraftdämpfende und zusammenschiebbare Lenksäulehalter.
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
ES1020711Y (es) Escuadra/palomilla perfeccionada.
ITMI921770A1 (it) Composizioni farmaceutiche atte al trattamento dei disturbi della memoria.
ES1021209Y (es) Sauna perfeccionada.
BR7201731U (pt) Espelho múltiplo regulável.
ES1021588Y (es) Portarrollos perfeccionados.
ES1033623Y (es) Soporte ornamental perfeccionado.
ES1023618Y (es) Columna perfeccionada, para soporte de baldas en estanterias y similares.
ES1026777Y (es) Atril plegable perfeccionado.
IT9047675A1 (it) Sedia traslocatore per assistenza di handicappati.
ES1031795Y (es) Baston perfeccionado.
ES1025240Y (es) Atril perfeccionado.